{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?AnsweringBody.=Department+of+Health+and+Social+Care&max-answer.questionFirstAnswered.=2019-02-14T17%3A46%3A27.347Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?AnsweringBody.=Department+of+Health+and+Social+Care&max-answer.questionFirstAnswered.=2019-02-14T17%3A46%3A27.347Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?AnsweringBody.=Department+of+Health+and+Social+Care&_metadata=all&max-answer.questionFirstAnswered.=2019-02-14T17%3A46%3A27.347Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&AnsweringBody.=Department+of+Health+and+Social+Care&max-answer.questionFirstAnswered.=2019-02-14T17%3A46%3A27.347Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?AnsweringBody.=Department+of+Health+and+Social+Care&max-answer.questionFirstAnswered.=2019-02-14T17%3A46%3A27.347Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?AnsweringBody.=Department+of+Health+and+Social+Care&max-answer.questionFirstAnswered.=2019-02-14T17%3A46%3A27.347Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1058750", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1058750/answer", "answerText" : {"_value" : "
Over the last five years, implementation of the United Kingdom antimicrobial resistance (AMR) strategy has been overseen and driven by a cross-Government High Level Steering Group, chaired by the Chief Medical Officer for England.<\/p>
<\/p>
Professor Dame Sue Hill, Chief Scientific Officer for NHS England, leads work to deliver the Government\u2019s ambitions for diagnostics as part of the strategy. NHS England established the UK AMR Diagnostics Collaborative to support delivery of the United Kingdom\u2019s diagnostics ambitions for AMR. The Collaborative has played a valuable role in developing the diagnostics elements of the new UK five-year national action plan on AMR, published in January this year.<\/p>
<\/p>
The Department continues to work closely with the UK AMR Diagnostics Collaborative, which currently has no plans to publish a report.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2019-02-14", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-14T17:44:29.493Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-11", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "UK Antimicrobial Resistance Diagnostics Collaborative"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what (a) representations his Department has received on the work of the UK Antimicrobial Resistance (AMR) Diagnostics Collaborative and (b) discussions have taken place between his Department and members of that group; what the timetable is for the publication of the AMR Diagnostics Collaborative's report; and (c) if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1604", "label" : {"_value" : "Biography information for Mr Virendra Sharma"} } , "tablingMemberConstituency" : {"_value" : "Ealing, Southall"} , "tablingMemberPrinted" : [{"_value" : "Mr Virendra Sharma"} ], "uin" : "219373"} , {"_about" : "http://data.parliament.uk/resources/1058752", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1058752/answer", "answerText" : {"_value" : "
No formal assessment has been made of the National AIDS Trust report however officials will consider its findings in the development of future drugs policy. The Government is concerned by the number of drug-related deaths and is supporting local areas to develop a more joined up approach to commissioning and delivering the range of services that are essential to supporting recovery and preventing drug-related deaths.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2019-02-14", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-14T17:45:27.307Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-11", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Death"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the implications for his Department's policies of the findings of the National Aids Trust report, Drug-Related Deaths in England, published by the National Aids Trust, published on 5 February 2019; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3973", "label" : {"_value" : "Biography information for Grahame Morris"} } , "tablingMemberConstituency" : {"_value" : "Easington"} , "tablingMemberPrinted" : [{"_value" : "Grahame Morris"} ], "uin" : "219400"} , {"_about" : "http://data.parliament.uk/resources/1058753", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1058753/answer", "answerText" : {"_value" : "
A Serious Shortage Protocol is an additional tool to manage and mitigate medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.<\/p>
As the explanatory memorandum of the amending Statutory Instrument acknowledges, protocols for therapeutic or generic equivalents will not be suitable for all medicines and patients. For example, such protocols would not be suitable for medicines that need to be prescribed by brand for clinical reasons, such as biological medicines. In these cases, patients would always be referred to the prescriber for any decision about their treatment before any therapeutic or generic alternative is supplied.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2019-02-14", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-14T17:35:25.567Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-11", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the proposed amendments to the Human Medicines Regulation 2012, what treatment areas will be excluded from the serious shortage protocol for reasons of patient safety; and if he will publish a list of medicines and formulations that will be excluded as a result.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4127", "label" : {"_value" : "Biography information for Julie Elliott"} } , "tablingMemberConstituency" : {"_value" : "Sunderland Central"} , "tablingMemberPrinted" : [{"_value" : "Julie Elliott"} ], "uin" : "219427"} , {"_about" : "http://data.parliament.uk/resources/1058800", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1058800/answer", "answerText" : {"_value" : "
The Government has been clear that it wants to change the focus of the health and care system onto prevention and Ministers have also set out an ambition for local pharmacies to play a stronger role in helping people stay well in the community. The Department has committed to publishing a Green Paper on prevention that will set out how these plans will be achieved in more detail. An assessment specifically focusing on the potential merits of nationally commissioning more public health services through community pharmacy has not been undertaken.<\/p>
An updated list of the 1,413 pharmacies found to be eligible for the pharmacy access scheme was published in January 2018, this is publicly available and can be found at the following link:<\/p>
<\/p><\/td> | Total number of eligible pharmacies<\/p><\/td> | Total number of pharmacies receiving zero payments<\/p><\/td> | Total number of pharmacies in receipt of payment<\/p><\/td><\/tr> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2016/17<\/p><\/td> | 1,402<\/p><\/td> | 47 (3%)<\/p><\/td> | 1,355 (97%)<\/p><\/td><\/tr> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2017/18<\/p><\/td> | 1,415[1]<\/sup><\/sup><\/p><\/td> 57 (4%)<\/p><\/td> 1,358 (96%)<\/p><\/td><\/tr><\/tbody><\/table> The fees and allowances paid under the Community Pharmacy Contractual Framework (CPCF) for the provision of essential services, including dispensing, provided by community pharmacies each year from April 2015 to March 2018 are detailed in the following table, based on data provided by NHS England. The structure of fees and allowances does not allow payments just for dispensing to be isolated. These payments do not include the medicine margin that community pharmacies earn as part of the payment for essential services, which is paid through reimbursement within the drugs\u2019 bill.<\/p> Enhanced services are locally commissioned. As such they are funded outside of the national CPCF and the Department does not hold the information sought.<\/p> Time period<\/p><\/td> Total essential services funding2<\/sup> /£<\/p><\/td> Total national CPCF funding (essential and advanced services) less medicines margin/ £<\/p><\/td> Funding for essential services as a proportion of total national CPCF funding (essential and advanced services) less medicines margin/ %<\/p><\/td><\/tr> 2015/16<\/p><\/td> 1,881,828,149<\/p><\/td> 2,000,000,000<\/p><\/td> 94<\/p><\/td><\/tr> 2016/17<\/p><\/td> 1,769,216,586<\/p><\/td> 1,887,000,000<\/p><\/td> 94<\/p><\/td><\/tr> 2017/18<\/p><\/td> 1,668,141,583<\/p><\/td> 1,792,000,000<\/p><\/td> 93<\/p><\/td><\/tr><\/tbody><\/table> Within the NHS Long Term Plan, Government has committed to expanding the number of pharmacists in Primary Care Networks. These pharmacists are well placed to work alongside the wider medical team to optimise the use of medicines, promote medicines adherence and improve the clinical and cost effectiveness of prescribed medications. Identifying and supporting patients on complex polypharmacy and those with long term conditions necessitating repeat prescriptions will form an important part of their role. Alongside this, in August 2018, NHS England, announced plans for a new pilot scheme, with investment of £1 million from the Pharmacy Integration Fund to develop system leadership within pharmacy across all settings. These pharmacy leaders will set the vision to systematically tackle medicines optimisation priorities for the local population within GP Network and Integrated Care System foot prints, further supporting medicines adherence, and in turn reducing medicines wastage.<\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-14", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "219279"}
, {"_value" : "219280"}
, {"_value" : "219281"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-14T17:46:27.253Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pharmacy: Public Health"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of nationally commissioning more public health services through community pharmacy.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/392", "label" : {"_value" : "Biography information for Sir Kevin Barron"}
}
, "tablingMemberConstituency" : {"_value" : "Rother Valley"}
, "tablingMemberPrinted" : [{"_value" : "Sir Kevin Barron"}
], "uin" : "219278"}
, {"_about" : "http://data.parliament.uk/resources/1058801", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1058801/answer", "answerText" : {"_value" : " The Government has been clear that it wants to change the focus of the health and care system onto prevention and Ministers have also set out an ambition for local pharmacies to play a stronger role in helping people stay well in the community. The Department has committed to publishing a Green Paper on prevention that will set out how these plans will be achieved in more detail. An assessment specifically focusing on the potential merits of nationally commissioning more public health services through community pharmacy has not been undertaken.<\/p> An updated list of the 1,413 pharmacies found to be eligible for the pharmacy access scheme was published in January 2018, this is publicly available and can be found at the following link:<\/p> <\/p><\/td> Total number of eligible pharmacies<\/p><\/td> Total number of pharmacies receiving zero payments<\/p><\/td> Total number of pharmacies in receipt of payment<\/p><\/td><\/tr> 2016/17<\/p><\/td> 1,402<\/p><\/td> 47 (3%)<\/p><\/td> 1,355 (97%)<\/p><\/td><\/tr> 2017/18<\/p><\/td> 1,415[1]<\/sup><\/sup><\/p><\/td> 57 (4%)<\/p><\/td> 1,358 (96%)<\/p><\/td><\/tr><\/tbody><\/table> The fees and allowances paid under the Community Pharmacy Contractual Framework (CPCF) for the provision of essential services, including dispensing, provided by community pharmacies each year from April 2015 to March 2018 are detailed in the following table, based on data provided by NHS England. The structure of fees and allowances does not allow payments just for dispensing to be isolated. These payments do not include the medicine margin that community pharmacies earn as part of the payment for essential services, which is paid through reimbursement within the drugs\u2019 bill.<\/p> Enhanced services are locally commissioned. As such they are funded outside of the national CPCF and the Department does not hold the information sought.<\/p> Time period<\/p><\/td> Total essential services funding2<\/sup> /£<\/p><\/td> Total national CPCF funding (essential and advanced services) less medicines margin/ £<\/p><\/td> Funding for essential services as a proportion of total national CPCF funding (essential and advanced services) less medicines margin/ %<\/p><\/td><\/tr> 2015/16<\/p><\/td> 1,881,828,149<\/p><\/td> 2,000,000,000<\/p><\/td> 94<\/p><\/td><\/tr> 2016/17<\/p><\/td> 1,769,216,586<\/p><\/td> 1,887,000,000<\/p><\/td> 94<\/p><\/td><\/tr> 2017/18<\/p><\/td> 1,668,141,583<\/p><\/td> 1,792,000,000<\/p><\/td> 93<\/p><\/td><\/tr><\/tbody><\/table> Within the NHS Long Term Plan, Government has committed to expanding the number of pharmacists in Primary Care Networks. These pharmacists are well placed to work alongside the wider medical team to optimise the use of medicines, promote medicines adherence and improve the clinical and cost effectiveness of prescribed medications. Identifying and supporting patients on complex polypharmacy and those with long term conditions necessitating repeat prescriptions will form an important part of their role. Alongside this, in August 2018, NHS England, announced plans for a new pilot scheme, with investment of £1 million from the Pharmacy Integration Fund to develop system leadership within pharmacy across all settings. These pharmacy leaders will set the vision to systematically tackle medicines optimisation priorities for the local population within GP Network and Integrated Care System foot prints, further supporting medicines adherence, and in turn reducing medicines wastage.<\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-14", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "219278"}
, {"_value" : "219280"}
, {"_value" : "219281"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-14T17:46:27.3Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pharmacy: Finance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will list each pharmacy in receipt of funding from the Pharmacy Access Scheme in each year since the establishment of that scheme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/392", "label" : {"_value" : "Biography information for Sir Kevin Barron"}
}
, "tablingMemberConstituency" : {"_value" : "Rother Valley"}
, "tablingMemberPrinted" : [{"_value" : "Sir Kevin Barron"}
], "uin" : "219279"}
, {"_about" : "http://data.parliament.uk/resources/1058802", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1058802/answer", "answerText" : {"_value" : " The Government has been clear that it wants to change the focus of the health and care system onto prevention and Ministers have also set out an ambition for local pharmacies to play a stronger role in helping people stay well in the community. The Department has committed to publishing a Green Paper on prevention that will set out how these plans will be achieved in more detail. An assessment specifically focusing on the potential merits of nationally commissioning more public health services through community pharmacy has not been undertaken.<\/p> An updated list of the 1,413 pharmacies found to be eligible for the pharmacy access scheme was published in January 2018, this is publicly available and can be found at the following link:<\/p> <\/p><\/td> Total number of eligible pharmacies<\/p><\/td> Total number of pharmacies receiving zero payments<\/p><\/td> Total number of pharmacies in receipt of payment<\/p><\/td><\/tr> 2016/17<\/p><\/td> 1,402<\/p><\/td> 47 (3%)<\/p><\/td> 1,355 (97%)<\/p><\/td><\/tr> 2017/18<\/p><\/td> 1,415[1]<\/sup><\/sup><\/p><\/td> 57 (4%)<\/p><\/td> 1,358 (96%)<\/p><\/td><\/tr><\/tbody><\/table> The fees and allowances paid under the Community Pharmacy Contractual Framework (CPCF) for the provision of essential services, including dispensing, provided by community pharmacies each year from April 2015 to March 2018 are detailed in the following table, based on data provided by NHS England. The structure of fees and allowances does not allow payments just for dispensing to be isolated. These payments do not include the medicine margin that community pharmacies earn as part of the payment for essential services, which is paid through reimbursement within the drugs\u2019 bill.<\/p> Enhanced services are locally commissioned. As such they are funded outside of the national CPCF and the Department does not hold the information sought.<\/p> Time period<\/p><\/td> Total essential services funding2<\/sup> /£<\/p><\/td> Total national CPCF funding (essential and advanced services) less medicines margin/ £<\/p><\/td> Funding for essential services as a proportion of total national CPCF funding (essential and advanced services) less medicines margin/ %<\/p><\/td><\/tr> 2015/16<\/p><\/td> 1,881,828,149<\/p><\/td> 2,000,000,000<\/p><\/td> 94<\/p><\/td><\/tr> 2016/17<\/p><\/td> 1,769,216,586<\/p><\/td> 1,887,000,000<\/p><\/td> 94<\/p><\/td><\/tr> 2017/18<\/p><\/td> 1,668,141,583<\/p><\/td> 1,792,000,000<\/p><\/td> 93<\/p><\/td><\/tr><\/tbody><\/table> Within the NHS Long Term Plan, Government has committed to expanding the number of pharmacists in Primary Care Networks. These pharmacists are well placed to work alongside the wider medical team to optimise the use of medicines, promote medicines adherence and improve the clinical and cost effectiveness of prescribed medications. Identifying and supporting patients on complex polypharmacy and those with long term conditions necessitating repeat prescriptions will form an important part of their role. Alongside this, in August 2018, NHS England, announced plans for a new pilot scheme, with investment of £1 million from the Pharmacy Integration Fund to develop system leadership within pharmacy across all settings. These pharmacy leaders will set the vision to systematically tackle medicines optimisation priorities for the local population within GP Network and Integrated Care System foot prints, further supporting medicines adherence, and in turn reducing medicines wastage.<\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-14", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "219278"}
, {"_value" : "219279"}
, {"_value" : "219281"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-14T17:46:27.347Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pharmacy: Expenditure"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how much and proportion of pharmacy funding has been spent on (a) dispensing and (b) enhanced services in each year since 2015-16.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/392", "label" : {"_value" : "Biography information for Sir Kevin Barron"}
}
, "tablingMemberConstituency" : {"_value" : "Rother Valley"}
, "tablingMemberPrinted" : [{"_value" : "Sir Kevin Barron"}
], "uin" : "219280"}
, {"_about" : "http://data.parliament.uk/resources/1058803", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1058803/answer", "answerText" : {"_value" : " The Government has been clear that it wants to change the focus of the health and care system onto prevention and Ministers have also set out an ambition for local pharmacies to play a stronger role in helping people stay well in the community. The Department has committed to publishing a Green Paper on prevention that will set out how these plans will be achieved in more detail. An assessment specifically focusing on the potential merits of nationally commissioning more public health services through community pharmacy has not been undertaken.<\/p> An updated list of the 1,413 pharmacies found to be eligible for the pharmacy access scheme was published in January 2018, this is publicly available and can be found at the following link:<\/p> <\/p><\/td> Total number of eligible pharmacies<\/p><\/td> Total number of pharmacies receiving zero payments<\/p><\/td> Total number of pharmacies in receipt of payment<\/p><\/td><\/tr> 2016/17<\/p><\/td> 1,402<\/p><\/td> 47 (3%)<\/p><\/td> 1,355 (97%)<\/p><\/td><\/tr> 2017/18<\/p><\/td> 1,415[1]<\/sup><\/sup><\/p><\/td> 57 (4%)<\/p><\/td> 1,358 (96%)<\/p><\/td><\/tr><\/tbody><\/table> The fees and allowances paid under the Community Pharmacy Contractual Framework (CPCF) for the provision of essential services, including dispensing, provided by community pharmacies each year from April 2015 to March 2018 are detailed in the following table, based on data provided by NHS England. The structure of fees and allowances does not allow payments just for dispensing to be isolated. These payments do not include the medicine margin that community pharmacies earn as part of the payment for essential services, which is paid through reimbursement within the drugs\u2019 bill.<\/p> Enhanced services are locally commissioned. As such they are funded outside of the national CPCF and the Department does not hold the information sought.<\/p> Time period<\/p><\/td> Total essential services funding2<\/sup> /£<\/p><\/td> Total national CPCF funding (essential and advanced services) less medicines margin/ £<\/p><\/td> Funding for essential services as a proportion of total national CPCF funding (essential and advanced services) less medicines margin/ %<\/p><\/td><\/tr> 2015/16<\/p><\/td> 1,881,828,149<\/p><\/td> 2,000,000,000<\/p><\/td> 94<\/p><\/td><\/tr> 2016/17<\/p><\/td> 1,769,216,586<\/p><\/td> 1,887,000,000<\/p><\/td> 94<\/p><\/td><\/tr> 2017/18<\/p><\/td> 1,668,141,583<\/p><\/td> 1,792,000,000<\/p><\/td> 93<\/p><\/td><\/tr><\/tbody><\/table> Within the NHS Long Term Plan, Government has committed to expanding the number of pharmacists in Primary Care Networks. These pharmacists are well placed to work alongside the wider medical team to optimise the use of medicines, promote medicines adherence and improve the clinical and cost effectiveness of prescribed medications. Identifying and supporting patients on complex polypharmacy and those with long term conditions necessitating repeat prescriptions will form an important part of their role. Alongside this, in August 2018, NHS England, announced plans for a new pilot scheme, with investment of £1 million from the Pharmacy Integration Fund to develop system leadership within pharmacy across all settings. These pharmacy leaders will set the vision to systematically tackle medicines optimisation priorities for the local population within GP Network and Integrated Care System foot prints, further supporting medicines adherence, and in turn reducing medicines wastage.<\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-14", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "219278"}
, {"_value" : "219279"}
, {"_value" : "219280"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-14T17:46:27.19Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Prescription Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps are being taken to (a) increase medicines adherence for repeat prescriptions and (b) reduce medicines wastage from repeat prescriptions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/392", "label" : {"_value" : "Biography information for Sir Kevin Barron"}
}
, "tablingMemberConstituency" : {"_value" : "Rother Valley"}
, "tablingMemberPrinted" : [{"_value" : "Sir Kevin Barron"}
], "uin" : "219281"}
, {"_about" : "http://data.parliament.uk/resources/1058809", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1058809/answer", "answerText" : {"_value" : " |